DE102008014560A1 - Vorrichtung, umfassend ein Quellmittel und eine Ummantelung, zur künstlichen Kallusdistraktion - Google Patents

Vorrichtung, umfassend ein Quellmittel und eine Ummantelung, zur künstlichen Kallusdistraktion Download PDF

Info

Publication number: DE102008014560A1
Authority: DE; Germany
Prior art keywords: sheath; swelling agent; preferred; bone; volume
Prior art date: 2008-03-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

DE102008014560A

Other languages

German (de)

English (en)

Inventor

Domonkos Dr. Horvath

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Celgen3d Ag Ch

Original Assignee

Celgen AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-15

Filing date

2008-03-15

Publication date

2009-09-24

2008-03-15 Application filed by Celgen AG filed Critical Celgen AG

2008-03-15 Priority to DE102008014560A priority Critical patent/DE102008014560A1/de

2008-03-15 Priority to DE102008064628A priority patent/DE102008064628A1/de

2009-03-14 Priority to JP2010550096A priority patent/JP5382739B2/ja

2009-03-14 Priority to EP09722885A priority patent/EP2252238A1/de

2009-03-14 Priority to PCT/EP2009/001875 priority patent/WO2009115251A1/de

2009-03-14 Priority to US12/922,534 priority patent/US9050190B2/en

2009-09-24 Publication of DE102008014560A1 publication Critical patent/DE102008014560A1/de

Status Withdrawn legal-status Critical Current

Links

230000008961 swelling Effects 0.000 title claims abstract description 109
206010020649 Hyperkeratosis Diseases 0.000 title abstract description 9
210000000988 bone and bone Anatomy 0.000 claims abstract description 91
238000000034 method Methods 0.000 claims abstract description 40
230000001172 regenerating effect Effects 0.000 claims abstract description 8
239000003795 chemical substances by application Substances 0.000 claims description 107
230000007547 defect Effects 0.000 claims description 59
230000008859 change Effects 0.000 claims description 57
239000000463 material Substances 0.000 claims description 54
241000446313 Lamella Species 0.000 claims description 26
239000007788 liquid Substances 0.000 claims description 22
230000010478 bone regeneration Effects 0.000 claims description 15
238000011069 regeneration method Methods 0.000 claims description 15
239000002775 capsule Substances 0.000 claims description 14
230000008929 regeneration Effects 0.000 claims description 14
229920000747 poly(lactic acid) Polymers 0.000 claims description 13
229920001610 polycaprolactone Polymers 0.000 claims description 12
239000004626 polylactic acid Substances 0.000 claims description 12
239000000017 hydrogel Substances 0.000 claims description 11
239000008280 blood Substances 0.000 claims description 9
210000004369 blood Anatomy 0.000 claims description 9
230000004956 cell adhesive effect Effects 0.000 claims description 8
239000008187 granular material Substances 0.000 claims description 8
229920000954 Polyglycolide Polymers 0.000 claims description 7
239000000560 biocompatible material Substances 0.000 claims description 7
239000000203 mixture Substances 0.000 claims description 7
230000001960 triggered effect Effects 0.000 claims description 7
230000000035 biogenic effect Effects 0.000 claims description 6
229920002732 Polyanhydride Polymers 0.000 claims description 5
239000004633 polyglycolic acid Substances 0.000 claims description 5
229920001397 Poly-beta-hydroxybutyrate Polymers 0.000 claims description 4
229920000331 Polyhydroxybutyrate Polymers 0.000 claims description 4
238000004519 manufacturing process Methods 0.000 claims description 4
229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims description 4
238000002360 preparation method Methods 0.000 claims description 2
210000004027 cell Anatomy 0.000 description 42
239000000835 fiber Substances 0.000 description 26
210000000963 osteoblast Anatomy 0.000 description 24
239000011148 porous material Substances 0.000 description 18
208000007536 Thrombosis Diseases 0.000 description 11
239000011248 coating agent Substances 0.000 description 11
238000000576 coating method Methods 0.000 description 11
230000011164 ossification Effects 0.000 description 11
239000002131 composite material Substances 0.000 description 10
102000004169 proteins and genes Human genes 0.000 description 10
108090000623 proteins and genes Proteins 0.000 description 10
IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 9
238000010521 absorption reaction Methods 0.000 description 9
239000003094 microcapsule Substances 0.000 description 9
210000002950 fibroblast Anatomy 0.000 description 8
108090000765 processed proteins & peptides Proteins 0.000 description 8
230000005540 biological transmission Effects 0.000 description 7
239000000316 bone substitute Substances 0.000 description 7
229920000642 polymer Polymers 0.000 description 7
210000001519 tissue Anatomy 0.000 description 7
239000011159 matrix material Substances 0.000 description 6
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 5
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 5
108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 5
210000002744 extracellular matrix Anatomy 0.000 description 5
239000012530 fluid Substances 0.000 description 5
238000003780 insertion Methods 0.000 description 5
230000037431 insertion Effects 0.000 description 5
239000007787 solid Substances 0.000 description 5
230000037303 wrinkles Effects 0.000 description 5
102000008186 Collagen Human genes 0.000 description 4
108010035532 Collagen Proteins 0.000 description 4
102000016359 Fibronectins Human genes 0.000 description 4
108010067306 Fibronectins Proteins 0.000 description 4
230000001464 adherent effect Effects 0.000 description 4
150000001413 amino acids Chemical group 0.000 description 4
230000027455 binding Effects 0.000 description 4
229920001436 collagen Polymers 0.000 description 4
239000010408 film Substances 0.000 description 4
230000008569 process Effects 0.000 description 4
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
239000002202 Polyethylene glycol Substances 0.000 description 3
239000000853 adhesive Substances 0.000 description 3
230000001070 adhesive effect Effects 0.000 description 3
239000001768 carboxy methyl cellulose Substances 0.000 description 3
235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
239000008112 carboxymethyl-cellulose Substances 0.000 description 3
230000021164 cell adhesion Effects 0.000 description 3
230000010261 cell growth Effects 0.000 description 3
229920001577 copolymer Polymers 0.000 description 3
210000002889 endothelial cell Anatomy 0.000 description 3
210000001650 focal adhesion Anatomy 0.000 description 3
239000012634 fragment Substances 0.000 description 3
150000004676 glycans Chemical class 0.000 description 3
239000003102 growth factor Substances 0.000 description 3
229920002674 hyaluronan Polymers 0.000 description 3
229960003160 hyaluronic acid Drugs 0.000 description 3
229910052588 hydroxylapatite Inorganic materials 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
210000005009 osteogenic cell Anatomy 0.000 description 3
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 3
229920001223 polyethylene glycol Polymers 0.000 description 3
229920001282 polysaccharide Polymers 0.000 description 3
239000005017 polysaccharide Substances 0.000 description 3
239000000126 substance Substances 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
208000032843 Hemorrhage Diseases 0.000 description 2
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
230000000735 allogeneic effect Effects 0.000 description 2
230000008901 benefit Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
230000000740 bleeding effect Effects 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
238000005253 cladding Methods 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
229910010272 inorganic material Inorganic materials 0.000 description 2
239000011147 inorganic material Substances 0.000 description 2
102000006495 integrins Human genes 0.000 description 2
108010044426 integrins Proteins 0.000 description 2
239000011368 organic material Substances 0.000 description 2
230000002188 osteogenic effect Effects 0.000 description 2
239000002245 particle Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
239000000843 powder Substances 0.000 description 2
102000005962 receptors Human genes 0.000 description 2
108020003175 receptors Proteins 0.000 description 2
230000009467 reduction Effects 0.000 description 2
239000000661 sodium alginate Substances 0.000 description 2
235000010413 sodium alginate Nutrition 0.000 description 2
229940005550 sodium alginate Drugs 0.000 description 2
238000001179 sorption measurement Methods 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
229920001169 thermoplastic Polymers 0.000 description 2
239000004416 thermosoftening plastic Substances 0.000 description 2
239000010936 titanium Substances 0.000 description 2
229910052719 titanium Inorganic materials 0.000 description 2
OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
238000012876 topography Methods 0.000 description 2
BUHVIAUBTBOHAG-FOYDDCNASA-N (2r,3r,4s,5r)-2-[6-[[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1=CC(OC)=CC(C(CNC=2C=3N=CN(C=3N=CN=2)[C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=2C(=CC=CC=2)C)=C1 BUHVIAUBTBOHAG-FOYDDCNASA-N 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
206010065687 Bone loss Diseases 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
102000009123 Fibrin Human genes 0.000 description 1
108010073385 Fibrin Proteins 0.000 description 1
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
206010018852 Haematoma Diseases 0.000 description 1
125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 1
206010054949 Metaplasia Diseases 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
229920001710 Polyorthoester Polymers 0.000 description 1
241000276425 Xiphophorus maculatus Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
210000001557 animal structure Anatomy 0.000 description 1
230000002965 anti-thrombogenic effect Effects 0.000 description 1
239000005312 bioglass Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
210000002449 bone cell Anatomy 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
230000001143 conditioned effect Effects 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
229920006037 cross link polymer Polymers 0.000 description 1
238000009799 cystectomy Methods 0.000 description 1
210000004292 cytoskeleton Anatomy 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
239000007857 degradation product Substances 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
239000000539 dimer Substances 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000009826 distribution Methods 0.000 description 1
230000007515 enzymatic degradation Effects 0.000 description 1
210000003722 extracellular fluid Anatomy 0.000 description 1
229950003499 fibrin Drugs 0.000 description 1
230000037406 food intake Effects 0.000 description 1
239000003292 glue Substances 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000005660 hydrophilic surface Effects 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
239000007943 implant Substances 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
230000002427 irreversible effect Effects 0.000 description 1
230000007794 irritation Effects 0.000 description 1
239000000832 lactitol Substances 0.000 description 1
VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
229960003451 lactitol Drugs 0.000 description 1
235000010448 lactitol Nutrition 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
102000006240 membrane receptors Human genes 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
230000015689 metaplastic ossification Effects 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000036629 mind Effects 0.000 description 1
230000008520 organization Effects 0.000 description 1
210000002997 osteoclast Anatomy 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
230000003239 periodontal effect Effects 0.000 description 1
201000001245 periodontitis Diseases 0.000 description 1
229920001308 poly(aminoacid) Polymers 0.000 description 1
229920002627 poly(phosphazenes) Polymers 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920002959 polymer blend Polymers 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
238000007789 sealing Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
210000002107 sheath cell Anatomy 0.000 description 1
230000019491 signal transduction Effects 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000010902 straw Substances 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
239000010409 thin film Substances 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
230000002792 vascular Effects 0.000 description 1
230000029663 wound healing Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0003—Not used, see subgroups
- A61C8/0004—Consolidating natural teeth
- A61C8/0006—Periodontal tissue or bone regeneration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Oral & Maxillofacial Surgery (AREA)
Animal Behavior & Ethology (AREA)
Transplantation (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Medicinal Chemistry (AREA)
Dermatology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Developmental Biology & Embryology (AREA)
Dentistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Materials For Medical Uses (AREA)

DE102008014560A 2008-03-15 2008-03-15 Vorrichtung, umfassend ein Quellmittel und eine Ummantelung, zur künstlichen Kallusdistraktion Withdrawn DE102008014560A1 (de)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
DE102008014560A DE102008014560A1 (de)	2008-03-15	2008-03-15	Vorrichtung, umfassend ein Quellmittel und eine Ummantelung, zur künstlichen Kallusdistraktion
DE102008064628A DE102008064628A1 (de)	2008-03-15	2008-03-15	Vorrichtung, umfassend ein Quellmittel und eine Ummantelung, zur künstlichen Kallusdistraktion
JP2010550096A JP5382739B2 (ja)	2008-03-15	2009-03-14	膨張剤及びシースを備える人工的な仮骨延長デバイス
EP09722885A EP2252238A1 (de)	2008-03-15	2009-03-14	Vorrichtung, umfassend ein quellmittel und eine ummantelung, zur künstlichen kallusdistraktion
PCT/EP2009/001875 WO2009115251A1 (de)	2008-03-15	2009-03-14	Vorrichtung, umfassend ein quellmittel und eine ummantelung, zur künstlichen kallusdistraktion
US12/922,534 US9050190B2 (en)	2008-03-15	2009-03-14	Device comprising a swelling agent and sheathing for artificial callus distraction

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102008014560A DE102008014560A1 (de)	2008-03-15	2008-03-15	Vorrichtung, umfassend ein Quellmittel und eine Ummantelung, zur künstlichen Kallusdistraktion
DE102008064628A DE102008064628A1 (de)	2008-03-15	2008-03-15	Vorrichtung, umfassend ein Quellmittel und eine Ummantelung, zur künstlichen Kallusdistraktion

Publications (1)

Publication Number	Publication Date
DE102008014560A1 true DE102008014560A1 (de)	2009-09-24

Family

ID=40984808

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE102008014560A Withdrawn DE102008014560A1 (de)	2008-03-15	2008-03-15	Vorrichtung, umfassend ein Quellmittel und eine Ummantelung, zur künstlichen Kallusdistraktion
DE102008064628A Withdrawn DE102008064628A1 (de)	2008-03-15	2008-03-15	Vorrichtung, umfassend ein Quellmittel und eine Ummantelung, zur künstlichen Kallusdistraktion

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE102008064628A Withdrawn DE102008064628A1 (de)	2008-03-15	2008-03-15	Vorrichtung, umfassend ein Quellmittel und eine Ummantelung, zur künstlichen Kallusdistraktion

Country Status (1)

Country	Link
DE (2)	DE102008014560A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102009042493A1 (de) *	2009-09-14	2011-04-21	Celgen Ag	Granulatmischung, umfassend zwei verschiedene Granulate, zur künstlichen Kallusdistraktion

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2015106247A1 (en) *	2014-01-13	2015-07-16	Westover Brock B	Endosseous dental implant assembly
DE202015004095U1 (de)	2015-06-03	2016-09-06	Nicolas Perren	Gewebedehnungsverstärker

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001091663A1 (de)	2000-05-29	2001-12-06	Domonkos Horvath	Vorrichtungen und medizinische membranen zur knochenregeneration
DE102004043325A1 (de) *	2003-09-12	2005-04-07	Aesculap Ag & Co. Kg	Chirurgische Vorrichtung
DE102006047248A1 (de) *	2006-10-06	2008-04-10	Celgen Ag	Dreidimensionale künstliche Kallusdistraktion

2008
- 2008-03-15 DE DE102008014560A patent/DE102008014560A1/de not_active Withdrawn
- 2008-03-15 DE DE102008064628A patent/DE102008064628A1/de not_active Withdrawn

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001091663A1 (de)	2000-05-29	2001-12-06	Domonkos Horvath	Vorrichtungen und medizinische membranen zur knochenregeneration
DE102004043325A1 (de) *	2003-09-12	2005-04-07	Aesculap Ag & Co. Kg	Chirurgische Vorrichtung
DE102006047248A1 (de) *	2006-10-06	2008-04-10	Celgen Ag	Dreidimensionale künstliche Kallusdistraktion

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102009042493A1 (de) *	2009-09-14	2011-04-21	Celgen Ag	Granulatmischung, umfassend zwei verschiedene Granulate, zur künstlichen Kallusdistraktion
US8617612B2 (en)	2009-09-14	2013-12-31	Celgen Ag	Granulated material mixture comprising two different granulated materials for artificial callus distraction
US9144582B2 (en)	2009-09-14	2015-09-29	Celgen3D Ag	Granulated material mixture comprising two different granulated materials for artificial callus distraction
DE102009042493B4 (de) *	2009-09-14	2016-07-21	Celgen3D Ag	Granulatmischung, umfassend zwei verschiedene Granulate, zur künstlichen Kallusdistraktion

Also Published As

Publication number	Publication date
DE102008064628A1 (de)	2009-09-17

Legal Events

Date	Code	Title	Description
2009-09-24	AH	Division in	Ref document number: 102008064628 Country of ref document: DE Kind code of ref document: P
2009-09-24	OP8	Request for examination as to paragraph 44 patent law
2014-03-24	R082	Change of representative	Representative=s name: GLEISS GROSSE SCHRELL UND PARTNER MBB PATENTAN, DE
2014-04-30	R081	Change of applicant/patentee	Owner name: CELGEN3D AG, CH Free format text: FORMER OWNER: CELGEN AG, ZUG, CH Effective date: 20140324
2014-04-30	R082	Change of representative	Representative=s name: GLEISS GROSSE SCHRELL UND PARTNER MBB PATENTAN, DE Effective date: 20140324
2016-09-23	R002	Refusal decision in examination/registration proceedings
2016-10-01	R119	Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Publication	Publication Date	Title
EP2079391B1 (de)	2013-02-27	Dreidimensionale künstliche kallusdistraktion
DE19953771C1 (de)	2001-06-13	Resorbierbares Knochen-Implantatmaterial sowie Verfahren zur Herstellung desselben
EP1948263B1 (de)	2013-07-03	Nervenleitschiene
EP2688533B1 (de)	2017-02-15	Primärauflage für die feuchte wundversorgung und verfahren zu deren herstellung
EP0609667B1 (de)	2003-01-08	Abdeckmembran
DE19654884C2 (de)	1999-07-29	Formkörper
EP1948257B1 (de)	2009-07-22	Formkörper auf basis eines vernetzten, gelatine enthaltenden materials, verfahren zu deren herstellung sowie deren verwendung
DE102018129658B4 (de)	2020-10-01	Medizinisches Implantat umfassend Magnesium und Fibroin
EP2686028B1 (de)	2016-02-10	Granulatmischung, umfassend zwei verschiedene granulate, zur künstlichen kallusdistraktion
WO2009115251A1 (de)	2009-09-24	Vorrichtung, umfassend ein quellmittel und eine ummantelung, zur künstlichen kallusdistraktion
DE102008014560A1 (de)	2009-09-24	Vorrichtung, umfassend ein Quellmittel und eine Ummantelung, zur künstlichen Kallusdistraktion
EP2477667B1 (de)	2014-11-12	Granulatmischung, umfassend zwei verschiedene granulate, zur künstlichen kallusdistraktion
CN107096065B (zh)	2019-11-15	含多聚唾液酸复合纳米纤维膜及制备方法和应用
DE102007024220A1 (de)	2008-11-20	Blutstillendes Vlies
EP1523956A2 (de)	2005-04-20	Vorrichtung zur Bildung von Gewebe und Zellkulturen, insbesondere Knochenregeneration mittels Distraktion
DE102010023794B4 (de)	2016-07-21	Medizinisches, insbesondere zahnmedizinisches Substrat
EP3700592A1 (de)	2020-09-02	Biokompatibles weichteilimplantat
DE102004035182B4 (de)	2008-05-29	Implantatmaterial, ein Verfahren zu seiner Herstellung und seine Verwendung
DE102010026322A1 (de)	2011-10-27	Chirurgische Implantate aus bioresorbierbaren und/oder biodegradierbaren Polymeren sowie Verfahren zu deren Herstellung
EP1506026A2 (de)	2005-02-16	Verwendung von chitosanmaterialien
WO2019096561A1 (de)	2019-05-23	Implantat und kit zum behandeln und/oder biologischen rekonstruieren eines knochendefekts
DE102007063395A1 (de)	2009-07-02	Transport-, Weitergabe- und/oder Wirksystem in aseptischer Darreichung
DE102019132938A1 (de)	2021-06-10	Verfahren zur Herstellung einer intraluminalen Endoprothese mit einer biodegradierbaren Hülle
DE102008054245A1 (de)	2010-04-29	Fixierungselement zum Fixieren von Gewebe und/oder Implantaten